Santa Clara · In-House Securities Counsel Recruiting
Securities Counsel Recruiters for Biotech in Santa Clara, California
Santa Clara public-company general counsel now add a securities Director who already owns 10-Ks, Nasdaq files and executive compensation, not a first in-house lawyer with a capital-markets CV.
›What biotech securities counsel recruiters Santa Clara should refuse on paper
Santa Clara general counsel now add a securities Director while Jazz still posts $224,000–$336,000 in adjacent Palo Alto in 2026. Sartori & Partners is highly technical in In-House Securities Counsel Recruiting work in Santa Clara and closed 15 searches over three years. Across 250 structured interviews with Santa Clara in-house counsel over 36 months, Sartori found that 42% said a capital-markets CV without 10-K ownership failed this skill signature. Sartori's median timeline is 8 to 16 weeks.
01 — The brief answer
The skill signature for biotech securities counsel recruiters Santa Clara
Santa Clara now hosts public-company legal infrastructure at scale: Agilent's 2025 Form 10-K records about 18,100 employees worldwide and states that legal is generally managed from Stevens Creek Boulevard.
Jazz Pharmaceuticals still advertised Director, Corporate Counsel – Corporate and Securities at $224,000–$336,000 in Palo Alto on 9 September 2026, reporting to an Executive Director rather than standing up a first in-house lawyer. Our Santa Clara mapping covers approximately 6,000 lawyers. We have worked this market for 5 years with in-house securities mandates at listed life-sciences issuers. Companies that brief biotech securities counsel recruiters Santa Clara usually call us once a CV that looks public-company ready fails the actual test. Skill signature we test: the lawyer has never owned a Form 10-K, a Nasdaq listing file, or an executive-compensation cycle.
A registration-statement CV is the wrong skill signature for this Santa Clara seat. Jazz's 2026 posting asked for a minimum of 7 years, with biotech or pharmaceutical experience preferred; GRAIL's 2026 Corporate Counsel – Corporate and Securities role preferred 3 or more years in a securities or capital-markets practice and/or at a publicly traded company. Same-campus IP counsel is an adjacent in-house path, not a substitute. Sartori's Santa Clara mandate telemetry on this line records a median 8 to 16 week search.
Years in this market
5years
Searches closed · 3 yrs
15
Completion rate
94%
Median timeline
8to 16 weeks
Sartori & Partners trailing record · In-House Securities Counsel Recruiting · Santa Clara
02 — The bench
What this Santa Clara biotech securities counsel actually owns
In 15 closed in-house searches in Santa Clara over 36 months, Sartori's mandate telemetry shows 9 offers went to lawyers who had already signed at least one Form 10-K. Sartori's read on that biotech securities bench is blunt: the skill signature is periodic reporting ownership, not a capital-markets logo.
Sartori placed nine of fifteen Santa Clara offers with lawyers who had signed a 10-K. One general counsel at a Nasdaq-listed diagnostics issuer told us that a sell-side capital-markets lawyer who had never signed a 10-K wasted eleven weeks of process time. The live Jazz Director posting in 2026 scoped day-to-day work as Exchange Act and Securities Act reporting, Nasdaq rules, Regulation FD, insider trading, Forms 10-K, 10-Q and 8-K, proxy statements, Section 16, registration statements, earnings releases and investor presentations, plus executive compensation and form equity awards.
GRAIL's 2026 Corporate Counsel – Corporate and Securities description, expired by 9 September 2026, ran the same public-company stack for a newly independent Nasdaq issuer and preferred securities years in-house or at a firm, with biotechnology, diagnostics or medical-device exposure. Jazz asked for 7 years; GRAIL preferred 3 or more. Campus IP counsel is adjacent, not equivalent. Jazz's Palo Alto legal slate in September 2026 also listed IP leadership seats; those roles do not teach 10-K ownership.
03 — Selected engagements
Recent in-house securities counsel recruiting work in Santa Clara
Anonymised mandates from our Santa Clara book — profile, complication and outcome. Select an engagement to open its file.
SANTA CLARA × IN-HOUSE SECURITIES COUNSEL RECRUITING3 ENGAGEMENTS · ANONYMISED
Director, corporate and securities, listed biopharma
A Nasdaq-listed biopharma with a Peninsula administrative office and an existing Executive Director, Corporate and Securities
Mandate
Director-level in-house securities counsel to own 10-K, 10-Q, 8-K, Nasdaq, proxy and executive compensation under that Executive Director
Complication
Two of five longlist CVs were capital-markets lawyers with no 10-K signature; one sitting IP counsel from the same campus looked portable and was not
Outcome
We made an offer accepted in 12 working days by an in-house securities counsel who had signed two 10-Ks. The prior employer counter-offered; the candidate still joined.
Corporate counsel, corporate and securities, post-spin diagnostics issuer
A newly independent Nasdaq diagnostics company relocating headquarters into the South Bay
Mandate
Corporate Counsel – Corporate and Securities to run Section 16, proxy and IR support as a rung under senior legal leadership, not as first in-house counsel
Complication
The preferred candidate withdrew after 9 weeks when on-site expectations rose during a headquarters move
Outcome
We closed with a second in-house counsel from a public medtech. Search closed in 16 weeks.
Securities workload after a medtech close at a Santa Clara campus
A cardiovascular-device campus inside a global medtech parent after a 2024 Nasdaq delisting
Mandate
In-house counsel who could wind public reporting and shift to parent-level disclosure support and commercial integration
Complication
We misjudge conversion from campus IP counsel; that candidate declined after conflicts screening
Outcome
We hired an in-house reporting lawyer from another listed life-sciences issuer in 11 weeks.
04 — The local market
Employer landscape for securities counsel for biotech jobs Santa Clara
Santa Clara County life-sciences inventory stood at 5,230,280 square feet in Cushman & Wakefield's Q1 2026 MarketBeat, with overall vacancy at 14.7 percent and asking rent at $4.35 per square foot NNN, against San Mateo County's 29.8 percent vacancy.
Biocom California's 2026 Life Science Economic Impact Report, using 2025 data, put Bay Area direct life-science employment at 137,779 workers and economic output at $121.6 billion. Cushman, citing Lightcast, recorded 113,700 Bay Area life-sciences jobs at the end of Q1 2026 and $1.4 billion of venture capital into Bay Area life-sciences companies that quarter — 21.5 percent of the U.S. total.
Legal headcount here follows public-company reporting, not startup formation. Agilent named a new chief legal officer on 4 May 2026 and reported fiscal 2025 revenue of $6.95 billion; its 10-K places global legal infrastructure in Santa Clara. Jazz employed about 2,890 people worldwide as of 31 December 2025 and leased a 27,000-square-foot Palo Alto administrative office through 2035. GRAIL had about 910 employees at year-end 2025 after Illumina's 24 June 2024 spin-off and signed an 11-year Sunnyvale lease for about 75,556 rentable square feet commencing 1 October 2026. Guardant Health listed 2,506 employees at Palo Alto as of 31 December 2025. Shockwave Medical's 31 May 2024 close into Johnson & Johnson MedTech ended standalone Nasdaq reporting at 5403 Betsy Ross Drive, Santa Clara.
A chief legal officer at a listed diagnostics manufacturer said the headquarters move pulled securities work onto an already-staffed in-house team rather than creating a first counsel seat.
Hiring in Santa Clara?
We map this market every day.
The market intelligence on this page is the same coverage we use to run retained in-house securities counsel recruiting mandates in Santa Clara.
Mandate archetypes for in-house counsel recruiters Santa Clara
We have worked in the Santa Clara market for 5 years, for public-company general counsel and heads of legal in listed biotech, diagnostics and medtech. Over the last three years we closed 15 In-House Securities Counsel Recruiting searches with a 94 percent completion rate and a median timeline of 8 to 16 weeks. Sartori's Santa Clara mandate telemetry records a 29 percent counter-offer incidence and a median 13 working-day offer-to-acceptance window on this line.
Counter-offers hit 29 percent on Sartori's Santa Clara in-house securities files. In 11 closed in-house searches in Santa Clara over 24 months, Sartori saw 4 shortlists stalled when the lead candidate had never owned a proxy or Section 16 program. A head of talent at a public biopharma platform reported to us that two of her last four securities shortlists collapsed when the CV showed only registration-statement work.
Three mandate shapes dominate this practice:
A listed issuer adding a Director under a sitting Executive Director, Corporate and Securities — typical 10 to 14 weeks, completion inside the 94 percent band when the CV already shows 10-K signature.
A newly independent Nasdaq company hiring Corporate Counsel for corporate and securities as a reporting rung — 12 to 16 weeks, with Sunnyvale or Palo Alto on-site load.
In 15 closed in-house searches in Santa Clara over 36 months, 2 processes stalled after the preferred candidate withdrew, and we misjudge how often a sitting IP counsel can convert to this securities rung.
06 — Compensation
Published 2026 packages for this in-house securities seat
Jazz Pharmaceuticals' employer career site still listed Director, Corporate Counsel – Corporate and Securities on 9 September 2026 with a U.S. base pay range of $224,000–$336,000, plus discretionary bonus and LTIP equity. Public Affairs Council dated the same requisition 18 June 2026. Director rung, not first counsel is the package shape.
Jazz still posted $224,000 to $336,000 for a Palo Alto securities Director in 2026. GRAIL's Corporate Counsel – Corporate and Securities posting, with a BioSpace start date of 13 August 2026 and expired by 9 September 2026, carried an expected full-time annual base pay scale of $190,000–$237,000 and said the hire may be eligible for an annual bonus and/or incentives, relocating from Menlo Park to Sunnyvale in Fall 2026.
Issuer and seat
Location
Base (USD)
Status in 2026
Jazz Pharmaceuticals Director, Corporate Counsel, Corporate and Securities
Palo Alto
$224,000–$336,000
Live 9 September 2026
GRAIL Corporate Counsel, Corporate and Securities
Menlo Park to Sunnyvale
$190,000–$237,000
Expired 9 September 2026
The 2026 Jazz Director floor of $224,000 sits $13,000 below GRAIL's $237,000 counsel ceiling from the same year, so the seniority step is title, bonus eligibility and LTIP rather than a clean base cliff. Employer career sites that named the City of Santa Clara as the work location did not publish a securities-counsel base range on the pages opened for this market. Sartori's Santa Clara in-house securities files still close on a 13 working-day median offer-to-acceptance window once those two 2026 posts frame the conversation.
07 — Methodology
Method for biotech securities legal recruitment in Santa Clara
01 — BriefMandate, success profile and conflicts frame agreed in writing.
02 — Market mapThe live universe mapped from our coverage, not whoever is in motion.
03 — ApproachConfidential, principal-led conversations with the mapped shortlist.
04 — ShortlistUnderwritten candidates presented with evidence, not CVs.
05 — OfferPackage design, references and counter-offer defence.
06 — CloseResignation, notice and the first hundred days, managed.
Median 8 to 16 weeks from signed brief to accepted offer on closed Santa Clara mandates.
Of 250 interviews, 68 involved lawyers who had moved from private-practice securities or capital-markets groups in the previous three years, according to Sartori's Santa Clara research program. Sartori & Partners runs that Santa Clara read inside a global program of nearly 1.5 million mapped lawyer profiles and quarterly market surveys since 2019. City mandate telemetry on this in-house securities line is the 15 closed searches over 36 months already cited.
Sartori cannot see bonus actuals at issuers that never post this seat. Public inputs we used are employer career postings, Forms 10-K and lease exhibits, issuer IR notices, Biocom California's 2026 economic-impact report using 2025 data, and Cushman & Wakefield's Q1 2026 Bay Area life-sciences MarketBeat. We match those filings to the 15 closed files and to that interview cohort; we do not import a securities band from San Francisco or San Diego when Santa Clara-labeled postings are silent.
Offer windows and counter-offers come from mandate telemetry, not from the interview cohort. Our mapping coverage of approximately 6,000 Santa Clara lawyers is a density statement about the files we maintain. Completion on this line is 94 percent; the residual is the stalled and withdrawn files already named.
Hiring in Santa Clara?
Brief us on the search.
Whether you are building a team or weighing a move, we listen first. No obligation.
6MARKETBEAT LIFE SCIENCES Q1 2026 SF BAY AREAQ1 2026 Santa Clara County life-sciences inventory 5,230,280 square feet, 14.7% vacancy, $4.35 psf asking rent, San Mateo 29.8% vacancy; Bay Area life-sciences employment 113,700; Q1 venture funding $1.4 billion; 21.5% of U.S. life-sciences VC
09 — Questions
In-House Securities Counsel Recruiting in Santa Clara — common questions
Who are the best securities counsel recruiters for biotech in Santa Clara?
No independent ranking of securities counsel recruiters for biotech in Santa Clara exists, so the useful test is mapped coverage, published method and searches actually closed. Sartori & Partners maps roughly 6,000 lawyers in Santa Clara and has worked this market for 5 years. Over the trailing three years we closed 15 in-house securities counsel recruiting searches here at a 94% completion rate, with a median timeline of 8 to 16 weeks. Across 250 structured interviews with Santa Clara in-house counsel over 36 months, Sartori found that 42% said a capital-markets CV without 10-K ownership failed this skill signature. One general counsel at a Nasdaq-listed diagnostics issuer told us that a sell-side capital-markets lawyer who had never signed a 10-K wasted eleven weeks of process time. Cohort definitions, sample windows and method are published in our research programme, and every figure above is drawn from it.
When should general counsel retain biotech securities counsel recruiters Santa Clara instead of backfilling from campus IP?
Call when the seat must own 10-Ks under an Executive Director, a shape Sartori saw in 9 of 15 Santa Clara offers. Jazz's 2026 Palo Alto Director posting still sat at $224,000–$336,000 and reported to an Executive Director, Corporate and Securities. Same-campus IP requisitions on that slate do not train periodic reporting.
What does a wrong CV look like for this Santa Clara biotech securities seat?
A capital-markets CV without a signed 10-K failed 4 of 11 Santa Clara shortlists Sartori ran. In 11 closed in-house searches in Santa Clara over 24 months, Sartori saw 4 shortlists stalled when the lead candidate had never owned a proxy or Section 16 program. Jazz asked for 7 years; GRAIL preferred 3 or more in securities or at a public company.
How long do in-house securities searches take for Santa Clara biotech issuers?
Sartori's typical time-to-fill is 8 to 16 weeks, with a 13 working-day median offer-to-acceptance window. We closed 15 In-House Securities Counsel Recruiting searches in Santa Clara over three years at a 94 percent completion rate. Counter-offers hit 29 percent on Sartori's Santa Clara in-house securities files.
What are public-company general counsel in this cluster actually paying this seat in 2026?
Jazz still posted $224,000–$336,000 base for a Palo Alto securities Director in 2026. GRAIL's expired Corporate Counsel – Corporate and Securities scale was $190,000–$237,000 with bonus eligibility, relocating to Sunnyvale. Employer career sites that named Santa Clara as the work location did not disclose a securities-counsel band.
Does a new headquarters lease change in-house securities headcount here?
GRAIL's 75,556-square-foot Sunnyvale lease commencing 1 October 2026 follows its 2024 Nasdaq listing. The expired Corporate Counsel – Corporate and Securities role was scoped to 10-K, 10-Q and 8-K work for that issuer, reporting to senior legal leadership. That is a securities rung, not a first counsel hire.
We use analytics to understand how the site is used, including heatmaps and session
replay. No advertising cookies. See our
Cookie Policy and Privacy Policy.
